EUVIMEDEUVIMED entdecken
Crossref

Complex intervention including pain science education and patient-led goal setting–based self-management strategies for management of aromatase inhibitor-induced musculoskeletal symptoms: a single-arm feasibility and pilot study

Masahiro Manfuku iD, Tomohiko Nishigami, Akira Mibu, Hirofumi Yamashita, Shuhei Ishida, Ryota Imai, Astrid Lahousse, Hiroe Kanamori, Kazuhiro Sumiyoshi

Journal of Cancer Survivorship · 2026-08 · 20 (4) · 1351-1366

DOI: 10.1007/s11764-024-01737-6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cancer Survivorship, online erschienen am 30.12.2024. Verfasst von Masahiro Manfuku und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rehabilitation, Breast Care Sensyu Clinic, Osaka, Japan. Hauptthemen laut MEDLINE: Aromatase Inhibitors, Breast Neoplasms, Patient Education as Topic, Self-Management. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 78 Literaturangaben. Gefördert von: Prefectural Hiroshima University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Up to 74% of breast cancer survivors (BCS) treated with aromatase inhibitor (AI) experience AI-induced musculoskeletal symptoms (AIMSS). AIMSS is the predominant cause of poor adherence to AI therapy, yet no definitive treatment exists. The primary research objectives of this study were (1) to develop a novel BCS-specific complex intervention to alleviate AIMSS, and to assess its feasibility. The secondary research objective was (2) to assess the preliminary efficacy of this intervention. METHODS: A single-arm, longitudinal pilot study was conducted involving 15 BCS with AIMSS. The complex intervention, which included pain science education, patient-led goal setting, and self-management strategies, was administered over 3 months. Feasibility was assessed by measuring overall participation, treatment completion rates, and satisfaction after 3 months of intervention. Additionally, the preliminary efficacy of the intervention was evaluated using a mixed model repeated measures analysis, with the change in pain intensity (brief pain inventory [BPI] worst pain/stiffness intensity) at 3 months as the primary endpoint. RESULTS: The feasibility assessment showed promising results, with a 70.7% participation rate, an 83.3% intervention completion rate, and a satisfaction score of 8.2 ± 1.5. The intervention significantly reduced BPI worst pain/stiffness intensity by 2.78 points after 3 months (95% CI, - 4.5 to - 0.87, p < 0.01). Secondary outcomes demonstrated significant improvements in disability, quality of life, and pain catastrophizing (p < 0.05). CONCLUSION: The novel complex intervention appears valuable for management AIMSS in BCS. Future large-scale studies, including randomized controlled trials, are warranted. TRIAL REGISTRATION: The study was registered in the Clinical Trials Registry of the University Hospital Medical Information Network (UMIN-CTR: UMIN 000049035) in October 2022. IMPLICATIONS FOR CANCER SURVIVORS: The novel BCS-specific complex intervention program holds the potential to aid in managing AIMSS, improving adherence to AI therapy, and enhancing their quality of life.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aromatase InhibitorsBreast NeoplasmsPatient Education as TopicSelf-ManagementMusculoskeletal DiseasesMusculoskeletal PainHumansFemalePilot ProjectsMiddle AgedFeasibility StudiesAgedLongitudinal StudiesCancer SurvivorsAdultGoals

Stichwörter der Autor:innen

Aromatase inhibitorAromatase inhibitor–induced musculoskeletal symptomsBreast cancerCancer painPain science educationPatient-led goal setting

Substanzen

Aromatase Inhibitors

Autor:innen und Institutionen

  • Department of Rehabilitation, Breast Care Sensyu Clinic, Osaka, Japan.
  • Graduate School of Comprehensive Scientific Research, Prefectural University of Hiroshima, Hiroshima, Japan.
  • Department of Physical Therapy, Faculty of Health and Welfare, Prefectural University of Hiroshima, Hiroshima, Japan. tomon@pu-hiroshima.ac.jp.
  • Department of Physical Therapy, Konan Women's University, Hyogo, Japan.
  • Department of Rehabilitation, Nozomi Orthopaedic Clinic Saijo, Hiroshima, Japan.
  • Department of Rehabilitation, Shimane University Hospital, Shimane, Japan.

ORCID-Profile: Masahiro Manfuku

Förderung

  • Prefectural Hiroshima University

Zitieren

APA

Manfuku, M., Nishigami, T., Mibu, A., Yamashita, H., Ishida, S., Imai, R., Lahousse, A., Kanamori, H., & Sumiyoshi, K. (2026). Complex intervention including pain science education and patient-led goal setting–based self-management strategies for management of aromatase inhibitor-induced musculoskeletal symptoms: a single-arm feasibility and pilot study. Journal of Cancer Survivorship, 20(4), 1351-1366. https://doi.org/10.1007/s11764-024-01737-6

Vancouver

Manfuku M, Nishigami T, Mibu A, Yamashita H, Ishida S, Imai R, et al. Complex intervention including pain science education and patient-led goal setting–based self-management strategies for management of aromatase inhibitor-induced musculoskeletal symptoms: a single-arm feasibility and pilot study. Journal of Cancer Survivorship. 2026;20(4):1351-1366. doi:10.1007/s11764-024-01737-6

BibTeX
@article{Manfuku2026,
  author = {Manfuku, Masahiro and Nishigami, Tomohiko and Mibu, Akira and Yamashita, Hirofumi and Ishida, Shuhei and Imai, Ryota and Lahousse, Astrid and Kanamori, Hiroe and Sumiyoshi, Kazuhiro},
  title = {Complex intervention including pain science education and patient-led goal setting–based self-management strategies for management of aromatase inhibitor-induced musculoskeletal symptoms: a single-arm feasibility and pilot study},
  journal = {Journal of Cancer Survivorship},
  year = {2026},
  volume = {20},
  number = {4},
  pages = {1351--1366},
  doi = {10.1007/s11764-024-01737-6}
}
Kostenlos starten →